Patricia Jakel Discusses Challenges for Patients with Breast Cancer Taking Novel Therapies
There is room to improve drug adherence, patient education, and adverse event (AE) management for interstitial lung disease and cardiac AEs, according to Patricia Jakel, RN, MN, AOCN.
Opinion: The Iris App Could Be a “Game-Changer” for Patients With Cancer
Iris app aims to leverage accessible technology to deliver supportive care to all patients with cancer.
Improving Inpatient Ambulation Remains a Critical Issue in Supporting Patients Posttransplant
Sarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, highlight the importance of improving inpatient ambulation for transplant patients.
Kormanik Explains Difference Between Accelerated Vs Regular Approvals in Oncology
Natasha Kormanik MSN, CRNP, FNP-BC, OCN, discusses accelerated vs regular approvals in hematologic oncology and how it applies to approved PI3K inhibitors.
Martone Comments on the Safety Profile of Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer
Brenda Martone MSN, ANP-BC, AOCNP, discusses the safety data from the phase 3 ARASENS trial.
Walton Discusses the Gaps in Current Safety Protocols on Inpatient Oncology Units
AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN, discusses the limitations of plastic-backed pads in inpatient oncology units.
Mahon on the Benefits and Challenges of PARP Inhibitors in Ovarian Cancer Treatment
Lauren Mahon, MSN, FNP-BC, outlines nursing considerations with approved PARP inhibitors.
Cullen Discusses Severe Oral Mucositis Management With Avasopasem
Elizabeth R. Cullen, MSN, ARNP, talks severe oral mucositis management for patients with locally advanced head and neck cancer.
Nurses Report Positive Patient Experiences After Allowing Cannabis in the Inpatient Cancer Unit
Amanda McKaig, BSN-RN, OCN; and Alyssa Ridad, BSN-RN, OCN, discuss how Ryan’s Law has changed their practice and how oncology nurses have responded to the changes.
Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy
Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.
Niccum Haag Highlights Importance of Patient Education For Patients With VHL-Associated Tumors
Heather Niccum Haag, BSN, RN, CCRN, shares how her institution improved patient education with the treatment belzutifan.
Quality Improvement Project Improves Timeliness of Antibiotic Administration in BMT Patients
Sabrina Banegas, RN, BMT-CN, highlights the value of improving antibiotic administration times for patients undergoing bone marrow transplant.
Abbey Kaler, MS, APRN, FNP-C, CMSRN, Wins CURE's 2023 Extraordinary Healer Award
Abbey Kaler, MS, APRN, FNP-C, CMSRN, demonstrated extraordinary oncology nursing by being a consistent champion of the patient’s voice.
Machine Learning May Be Useful in Predicting AEs in Head and Neck Cancer
Meredith Cummings, BSN, RN, OCN, discusses the potential benefit of machine learning in predicting symptoms for patients with head and neck cancer.
Meredith Cummings on Using Machine Learning to Predict Treatment-Related Adverse Events
Meredith Cummings BSN, RN, OCN, highlights her research on machine learning and its potential application in optimizing symptom management.
Oral Cryotherapy Aids in Reducing the Prevalence of Mucositis in Patients with Breast Cancer
Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss their research on oral cryotherapy as a mucositis mitigation strategy.
Multidisciplinary Teamwork Yields Improvements in HSCT Workflow and Care
Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP; and Tia Wheatley, DNP, RN, AOCNS, BMTCN, highlight the value of multidisciplinary approaches in hematopoietic stem cell transplantation care.
Repeated Hematologic Evaluations May Not be Necessary for Patients Receiving ICIs
Yelena Shames, MSA, ACNP-BC, CNRN, argues that frequent hematologic evaluations may not always be warranted with immune checkpoint inhibitors.
Increasing Nurse Autonomy in Managing Infusion-Related Reactions Is Paramount
Appropriate monitoring of infusion-related reactions requires up-to-date knowledge of the latest criteria for adverse event management, health system policies, and protocols for reporting.
Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting
Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.
Weighted Blankets Effectively Reduce Anxiety for Patients Undergoing Cancer Treatment
Applying weighted blankets for 20 minutes reduced patient anxiety during cancer infusions.
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
Alyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Standardized Videos on the Double-Check Process Aims to Help Nurses Administer High-Alert Medications
Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, discusses how her institution improved double-check compliance with high-alert medications.
EMR App Increases Patient Referrals to the Leukemia & Lymphoma Society
Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, describes how nurses used an app imbedded in the electronic medical record to refer patients to the Leukemia & Lymphoma Society.
Johanna Garibaldi On Strengthening Cancer Prevention Tactics With Mobile Screening Clinics
Johanna Garibaldi, BSN, RN, EMT-P, discusses how a mobile clinic improved cancer screening rates among local firefighters.
Formation of an Oncology Nurse Leader Council Promotes Frontline Nurse Engagement
Elizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN, highlights how the Oncology Nurse Leader Council at her institution led to frontline nurse task-force engagement.
Elizabeth Cullen Discusses Avasopasem Manganese As A Potential Mucositis Management Strategy in Head and Neck Cancers
Elizabeth R. Cullen, MSN, ARNP, provides an overview of avasopasem manganese and its potential role in reducing severe oral mucositis for patients undergoing radiotherapy.
Early Intervention for CRS Is Key for Patients With Multiple Myeloma Receiving Bispecific Antibodies
Donna Catamero, ANP-BC, OCN, CCRC, highlights best nursing practices with teclistamab.
Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT Care
Tia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.
Pattie Jakel Highlights the Challenges With Oral Therapies in Breast Cancer
Patricia Jakel, RN, MN, AOCN, underscores some of the challenges nurses face when promoting adherence to oral medications.
PVd Confers a Small OS Benefit to Patients With Relapsed/Refractory Multiple Myeloma
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
2 Clarke Drive Cranbury, NJ 08512